Courier Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,666
| Closed | -$308K | – | 286 |
|
|
2022
Q2 | $308K | Hold |
5,666
| – | – | 0.04% | 222 |
|
|
2022
Q1 | $308K | Sell |
5,666
-740
| -12% | -$40.2K | 0.03% | 234 |
|
|
2021
Q4 | $353K | Buy |
6,406
+10
| +0.2% | +$520 | 0.03% | 222 |
|
|
2021
Q3 | $305K | Buy |
6,396
+10
| +0.2% | +$502 | 0.03% | 247 |
|
|
2021
Q2 | $318K | Buy |
6,386
+12
| +0.2% | +$577 | 0.03% | 243 |
|
|
2021
Q1 | $284K | Buy |
6,374
+8
| +0.1% | +$363 | 0.03% | 249 |
|
|
2020
Q4 | $293K | Hold |
6,366
| – | – | 0.03% | 234 |
|
|
2020
Q3 | $293K | Sell |
6,366
-182
| -3% | -$9.12K | 0.04% | 219 |
|
|
2020
Q2 | $337K | Hold |
6,548
| – | – | 0.04% | 196 |
|
|
2020
Q1 | $337K | Buy |
6,548
+16
| +0.2% | +$853 | 0.05% | 183 |
|
|
2019
Q4 | $381K | Buy |
6,532
+7
| +0.1% | +$389 | 0.04% | 197 |
|
|
2019
Q3 | $338K | Buy |
6,525
+8
| +0.1% | +$412 | 0.04% | 202 |
|
|
2019
Q2 | $326K | Buy |
6,517
+649
| +11% | +$32.6K | 0.04% | 207 |
|
|
2019
Q1 | $307K | Sell |
5,868
-1,352
| -19% | -$67.6K | 0.04% | 214 |
|
|
2018
Q4 | $345K | Buy |
7,220
+208
| +3% | +$10.2K | 0.05% | 184 |
|
|
2018
Q3 | $352K | Buy |
7,012
+1,007
| +17% | +$51.2K | 0.04% | 209 |
|
|
2018
Q2 | $303K | Sell |
6,005
-1,190
| -17% | -$59.9K | 0.04% | 230 |
|
|
2018
Q1 | $351K | Buy |
7,195
+409
| +6% | +$19K | 0.05% | 207 |
|
|
2017
Q4 | $301K | Buy |
6,786
+807
| +13% | +$37.3K | 0.04% | 221 |
|
|
2017
Q3 | $303K | Sell |
5,979
-794
| -12% | -$40.3K | 0.04% | 207 |
|
|
2017
Q2 | $365K | Buy |
6,773
+8
| +0.1% | +$426 | 0.06% | 183 |
|
|
2017
Q1 | $357K | Buy |
6,765
+144
| +2% | +$7.3K | 0.06% | 187 |
|
|
2016
Q4 | $319K | Buy |
6,621
+1,135
| +21% | +$56.1K | 0.06% | 193 |
|
|
2016
Q3 | $296K | Sell |
5,486
-1,594
| -23% | -$87.4K | 0.06% | 214 |
|
|
2016
Q2 | $384K | Buy |
7,080
+1,615
| +30% | +$85.1K | 0.08% | 183 |
|
|
2016
Q1 | $277K | Sell |
5,465
-72
| -1% | -$3.59K | 0.06% | 226 |
|
|
2015
Q4 | $279K | Sell |
5,537
-775
| -12% | -$39.5K | 0.06% | 217 |
|
|
2015
Q3 | $303K | Buy |
6,312
+7
| +0.1% | +$364 | 0.07% | 202 |
|
|
2015
Q2 | $328K | Sell |
6,305
-508
| -7% | -$28.6K | 0.07% | 196 |
|
|
2015
Q1 | $393K | Sell |
6,813
-113
| -2% | -$6.48K | 0.08% | 181 |
|
|
2014
Q4 | $370K | Buy |
6,926
+7
| +0.1% | +$392 | 0.07% | 188 |
|
|
2014
Q3 | $398K | Buy |
6,919
+88
| +1% | +$5.39K | 0.08% | 180 |
|
|
2014
Q2 | $457K | Buy |
6,831
+7
| +0.1% | +$474 | 0.09% | 166 |
|
|
2014
Q1 | $456K | Buy |
6,824
+6
| +0.1% | +$406 | 0.09% | 163 |
|
|
2013
Q4 | $455K | Buy |
6,818
+54
| +0.8% | +$3.5K | 0.1% | 160 |
|
|
2013
Q3 | $424K | Buy |
6,764
+85
| +1% | +$5.47K | 0.1% | 159 |
|
|
2013
Q2 | $417K | Buy |
+6,679
| New | +$424K | 0.1% | 157 |
|
Other funds holding GSK
Courier Capital's GSK Position: Q3 2022 in Review
Courier Capital sold out of GSK (GSK) in Q3 2022, closing a stake of 5,666 shares — an estimated $308K sold.
Courier Capital first reported a position in GSK in Q2 2013 and held it in 37 quarters. The position peaked at $457K in Q2 2014. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.
- Courier Capital reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
- Courier Capital sold 5,666 GSK shares in Q3 2022, an estimated $308K.
- Courier Capital first reported a position in GSK in Q2 2013 and held it in 37 quarters.
- Courier Capital's GSK position peaked at $457K in Q2 2014.
- 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.
Based on Courier Capital's 13F filing for Q3 2022, filed 18 Oct 2022.